Skip to main content
Journal of Genetic Engineering and Biotechnology

Table 6 The IOP average as well as the systemic oxidative stress in PACG patients using or not using the topical glaucoma medications

From: Impact of rs11024102 PLEKHA7, rs3753841 COL11A1 single nucleotide polymorphisms, and serum levels of oxidative stress markers on the risk of primary angle-closure glaucoma in Egyptians

 

Intraocular medications (no),

(n = 2)

Intraocular medications (yes),

(n= 34)

T value

P value

IOP average (mm Hg)

21.25±3.75

21.38±0.96

−0.03

0.974

MDA (nmol/ml)

5.45±0.65

9.52±0.44

−2.33

0.033

AOPP (mmol/L)

92.60±12.37

101.83±5.08

−0.43

0.668

PC (nmol/ml)

14.47±0.34

15.03±0.45

−0.30

0.769

IMA (ABSU)

0.45±0.01

0.24±0.01

2.91

0.006

  1. Data are expressed as mean ± SE
  2. PACG primary angle-closure glaucoma, MDA malondialdehyde, AOPP advanced oxidation protein products, PC protein carbonyl, IMA ischemia-modified albumin, ABSU absorbance units
  3. The statistical analysis was performed on PACG patients after excluding subjects with DM, hypertension, CVD, and smoking
  4. P < 0.05 was considered significant
Back to article page